The hazards of liquid nitrogen in a cryogenic facility arise from four primary properties: extreme cold causing cryogenic burns and frostbite on contact with skin or eyes; rapid expansion from liquid to gas at a ratio of approximately 1:694 at atmospheric pressure creating asphyxiation and explosion risk in enclosed spaces; displacement of atmospheric oxygen causing hypoxia at concentrations below 19.5 percent; and high-pressure build-up in sealed containers causing catastrophic vessel failure.
The Health and Safety Executive (HSE) classifies liquid nitrogen handling under the Dangerous Substances and Explosive Atmospheres Regulations 2002 (DSEAR) and the Control of Substances Hazardous to Health Regulations 2002 (COSHH). A COSHH risk assessment is legally required before liquid nitrogen is used in any UK workplace. Key controls mandated by HSE guidance and the British Compressed Gases Association (BCGA) Code of Practice CP30 include continuous atmospheric oxygen monitoring with audible and visual alarms calibrated to trigger at 19.5 percent oxygen concentration, personal protective equipment including cryogenic gloves rated to minus 196 degrees Celsius, face shields, and non-absorbent footwear, and storage of dewars only in well-ventilated rooms with mechanical ventilation providing a minimum of ten air changes per hour.
In IVF cryogenic facilities, additional hazards arise from the biological status of stored samples and the consequences of nitrogen loss. HFEA-licensed storage facilities require alarm systems that notify designated staff immediately on temperature deviation or nitrogen level drop. The HSE estimates that workplace injuries involving cryogenic liquids cost UK employers an average of £8,500 per incident in direct and indirect costs, excluding any clinical liability arising from sample loss in a licensed fertility facility. Cryolab supplies UKCA and CE marked cryogenic storage vessels engineered to minimise nitrogen consumption and support safe clinical operations at cryolab.co.uk.
